How much funding has Redx Pharma raised?

Redx Pharma has raised $17.1M in total funding, most recently a Corporate Round.

Who are Redx Pharma's investors?

Redx Pharma's investors include Sofinnova Partners, Redmile Group.

When was Redx Pharma founded?

Redx Pharma was founded in 2010.

Where is Redx Pharma headquartered?

Redx Pharma is headquartered in Macclesfield, United Kingdom.

What industry is Redx Pharma in?

Redx Pharma operates in Biotech, Healthcare.

How many employees does Redx Pharma have?

Redx Pharma has 51-200 employees.

Redx Pharma

Macclesfield, United Kingdom · Founded 2010 · $17.1M raised

Biotech

Healthcare

Headquarters: Macclesfield
Employees: 51–200
Founded: 2010
Business Model: B2B

Website: redxpharma.com
Total Funding: $17.1M
Last Round: $17.1M Corporate RoundOct 2023
Rounds: 1

About

Redx Pharma is a clinical-stage biotechnology company headquartered in Macclesfield, UK, focused on the discovery and development of novel small molecule targeted medicines for fibrotic diseases and oncology. The company's lead program, RXC008, is a potential first-in-class GI-restricted pan-ROCK inhibitor in Phase 2 development for fibrostenotic Crohn's disease. Its pipeline also includes zelasudil (RXC007), a selective ROCK2 inhibitor for interstitial lung diseases, and zamaporvint (RXC004), a Porcupine inhibitor for Wnt-ligand driven cancers. Redx has successfully partnered programs with AstraZeneca, Loxo Oncology, and Jazz Pharmaceuticals.

Summary

Redx Pharma is a Biotech company based in Macclesfield, United Kingdom, founded in 2010. It has raised $17.1M in total across 1 round, most recently a $17.1M Corporate Round round in Oct 2023. Investors include Sofinnova Partners and Redmile Group.